Sionna Therapeutics, Inc.
NASDAQ:SIONBiotechnology
+$0.68 today
- Market cap
- $134.35M
- Beta
- 1.29
- P/E (TTM)
- -19.7
- EPS (TTM)
- -$1.90
Volume 0.52M
Average 0.39M
SION Total Assets
Everything the company owns or controls; equal to total liabilities plus equity.
Sionna Therapeutics, Inc.NASDAQ: SION
Total Assets · Q1 FY2026 · quarter ended Mar 2026
Total assets falls 17.5% from a year ago
Total assets stood at $305.04M at the end of Q1 FY2026, down 17.5% from a year earlier and down 6.4% from the prior quarter. Over 3 fiscal years it compounded at +55.1% a year.
Context
- Total assets increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether total assets keeps falling in the next quarterly balance sheet after a -17.5% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Assets history
USD · from the balance sheet
- Latest · FY2025
- 325.95M USD
- Year-over-year change
- +75.5%
- 3-year CAGR
- +55.1%
| Period | Period end | Total Assets | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 325.95M | +75.5% |
| FY2024 | 2024-12-31 | 185.75M | +257.6% |
| FY2023 | 2023-12-31 | 51.95M | -40.5% |
| FY2022 | 2022-12-31 | 87.37M | — |
Total Assets vs competitors
How SION compares with its peers on the latest reported figures
- SION's Mar 2026 total assets of $305.04M is the lowest of the 11 companies compared; the peer median is $519.26M.
- Its year-over-year change of -17.5% is the 10th highest of 11, against a peer median of +17.1%.
- Over three fiscal years its annual growth of +55.1% compares with a peer median of +28.2%.
| Company | Period | Latest balance | YoY | 3-year CAGR |
|---|---|---|---|---|
| Sep 2026 | $1.5B | +10.6% | -4.1% | |
| Sep 2026 | $1.18B | +196.1% | -18.9% | |
| Mar 2026 | $1.03B | -2.1% | +40.4% | |
| Sep 2026 | $721.53M | +11.3% | +18.2% | |
| Jun 2026 | $532.98M | -7.9% | +77.5% | |
| Sep 2026 | $505.53M | +68.9% | +205.1% | |
| Mar 2026 | $504.51M | +23.0% | +38.2% | |
| Mar 2026 | $419.71M | +26.1% | +38.4% | |
| Mar 2026 | $392.01M | +24.3% | +3.6% | |
| Jun 2026 | $370.74M | -32.6% | -12.0% | |
| Mar 2026 | $305.04M | -17.5% | +55.1% | |
| Peer median (excluding SION) | $519.26M | +17.1% | +28.2% | |
Competitors are the stored peer set for SION. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Sionna Therapeutics, Inc.
NASDAQ:SION
Intrinsic Alpha fair value
Locked
Current Price
$2.97
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.